Stimuli-responsive polymers can respond to internal stimuli, such as reactive oxygen
species (ROS), glutathione (GSH), and pH, biological stimuli, such as enzymes, and external …

Polymeric nanoparticles have been widely used as carriers of drugs and bioimaging agents
due to their excellent biocompatibility, biodegradability, and structural versatility. The …

As drug carriers for cancer treatment, stimulus-responsive polymer nanomaterials are a
major research focus. These nanocarriers respond to specific stimulus signals (eg, pH …

A bioresponsive polymeric nanocarrier for drug delivery is able to alter its physical and
physicochemical properties in response to a variety of biological signals and pathological …

The conventional chemotherapeutic agents, used for cancer chemotherapy, have major
limitations including non-specificity, ubiquitous biodistribution, low concentration in tumor …

The emergence and development of nanomedicine have alleviated problems existing in
traditional chemotherapy drugs, such as short lifetime, concomitant side effects, and weak …

In the past few decades, polymeric nanocarriers have been recognized as promising tools
and have gained attention from researchers for their potential to efficiently deliver bioactive …

Polymeric nanocarriers have an increasingly growing potential for clinical applications. The
current and future expectation from a polymeric nanocarrier is to exhibit both diagnostic and …

In the last decade, considerable attention has been devoted to the use of biodegradable
polymeric materials as potential drug delivery carriers. However, bioavailability and drug …

The complexity of the tumor microenvironment presents significant challenges to cancer
therapy, while providing opportunities for targeted drug delivery. Using characteristic signals …